A Humanized Monoclonal Antibody Potentiates Killing of Diverse Biofilm-Forming Respiratory Tract Pathogens by Antibiotics
Sign Up to like & getrecommendations! Published in 2022 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.01877-21
Abstract: New strategies to treat diseases in which biofilms contribute significantly to pathogenesis are needed, as biofilm-resident bacteria are highly recalcitrant to antibiotics due to physical biofilm architecture and a canonically quiescent metabolism, among many additional… read more here.
Keywords: tract pathogens; monoclonal antibody; respiratory tract; humanized monoclonal ... See more keywords
Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potency
Sign Up to like & getrecommendations! Published in 2017 at "Molecular Neurodegeneration"
DOI: 10.1186/s13024-017-0172-1
Abstract: BackgroundThe experience from clinical trials indicates that anti-Aβ immunotherapy could be effective in early/pre-clinical stages of AD, whereas at the late stages promoting the clearing of Aβ alone may be insufficient to halt the disease… read more here.
Keywords: tau; mab armanezumab; pathological tau; humanized monoclonal ... See more keywords
A Case of Oral Candidiasis Caused by Candida dubliniensis During Treatment of Humanized Monoclonal Antibody to Interleukin-17A.
Sign Up to like & getrecommendations! Published in 2022 at "Medical mycology journal"
DOI: 10.3314/mmj.22-00010
Abstract: We report the case of a 77-year-old woman who had been diagnosed with psoriasis vulgaris at another hospital at age 33 and treated with various therapies since then. At 61 years old, she was diagnosed… read more here.
Keywords: monoclonal antibody; antibody interleukin; treatment humanized; humanized monoclonal ... See more keywords